How Might Anti-Obesity Medication Look Like in the Future?

Show notes

Watch the full video on YouTube to explore the future of anti-obesity medications and emerging therapeutic strategies.

In this episode, experts, Dr. Daniela Liśkiewicz and Dr. Juan Pablo Frías discuss the rapid evolution of obesity pharmacotherapy, from GLP-1 receptor agonists to next-generation combination treatments and oral therapies.

Key topics include:

  • The shift from injectable to oral and longer-acting medications
  • Multi-agonist therapies targeting multiple metabolic pathways
  • The importance of “quality weight loss” and preserving muscle mass
  • Challenges in long-term weight maintenance and preventing regain
  • The role of lifestyle intervention alongside pharmacotherapy
  • Future targets, including metabolic “set point” regulation

Explore more about the speakers:

  1. Dr Daniela Liśkiewicz
  2. Dr Juan Pablo Frias

For more episodes, visit our podcast archive.

New comment

Your name or nickname, will be shown publicly
At least 10 characters long
By submitting your comment you agree that the content of the field "Name or nickname" will be stored and shown publicly next to your comment. Using your real name is optional.